Studies described below show that the pretreatment status of PDGFr-β and its ligand PDGF-B in human pancreatic cancer xenografts is radically altered during therapeutic intervention with imatinib, radioactivity or both. The gene discussed is PDGFRB; the disease is familial pancreatic carcinoma.